HELIUS MEDICAL TECHNOLOGIES ($HSDT) posted quarterly earnings results on Tuesday, November 18th. The company reported earnings of -$32.89 per share, beating estimates of -$51.51 by $18.62. The company also reported revenue of $700,000, beating estimates of $112,200 by $587,800.
You can see Quiver Quantitative's $HSDT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HELIUS MEDICAL TECHNOLOGIES Hedge Fund Activity
We have seen 15 institutional investors add shares of HELIUS MEDICAL TECHNOLOGIES stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PANTERA CAPITAL PARTNERS LP added 7,774,638 shares (+inf%) to their portfolio in Q3 2025, for an estimated $115,764,359
- POLAR ASSET MANAGEMENT PARTNERS INC. added 2,179,916 shares (+inf%) to their portfolio in Q3 2025, for an estimated $32,458,949
- ARISTEIA CAPITAL, L.L.C. added 1,089,957 shares (+inf%) to their portfolio in Q3 2025, for an estimated $16,229,459
- CITADEL ADVISORS LLC added 728,857 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,852,680
- GHISALLO CAPITAL MANAGEMENT LLC added 726,638 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,819,639
- VR ADVISORY SERVICES LTD added 581,310 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,655,705
- HEL VED CAPITAL MANAGEMENT LTD added 435,983 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,491,786
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
